|
Females
|
|
Cluster 1
|
|
Utilized treatment*
|
0
|
NA
|
NA
|
|
Did not utilize treatment
|
4
|
20.98 (5.84)
|
0.47 (0.25)
|
|
Cluster 2
|
|
Utilized treatment*
|
21
|
37.78 (12.88)
|
31.94 (41.87)
|
|
Did not utilize treatment
|
105
|
34.38 (10.92)
|
24.42 (24.09)
|
|
Males
|
|
Cluster 1
|
|
Utilized treatment*
|
4
|
30.0 (0.0)
|
0.69 (0.0)
|
|
Did not utilize treatment
|
1
|
39.0 (0.0)
|
1.16 (0.0)
|
|
Cluster 2
|
|
Utilized treatment*
|
28
|
33.52 (10.78)
|
17.16 (7.71)
|
|
Did not utilize treatment
|
102
|
30.71 (11.13)
|
17.07 (7.45)
|
|
Cluster 3
|
|
Utilized treatment*
|
72
|
34.94 (11.09)
|
98.61 (58.16)
|
|
Did not utilize treatment
|
128
|
31.87 (12.39)
|
77.22 (42.61)
|
